Healthcare IT Today

NOVEMBER 6, 2023

This strategic consolidation establishes PicnicHealth as the leading patient-centric evidence-generation partner within a rapidly evolving life sciences landscape. By combining forces, we can unlock the potential of patient-centered studies and provide best-in-class solutions to support therapeutic development.”

Life Science 112

Life Science Drug Development Patient Experience healthcare technology 112

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 101

Life Science Drug Development Digital Health Health IT 101

Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Healthcare IT Today

OCTOBER 6, 2023

This platform is designed to meet the demands of health systems and life science companies working to solve increasingly global, diverse, and data-intensive healthcare problems. Atropos’ unique global offerings help life science leaders overcome this challenge.

Life Science 115

Life Science Drug Development Pharmaceuticals Health IT 115

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

MARCH 16, 2023

The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare IT Today

JULY 20, 2023

We are particularly excited about the ability of these tools to drive more efficient and faster drug development processes in the biopharma industry.” “The About Novalis LifeSciences LLC Novalis LifeSciences is the investment arm of Novalis Capital Partners, a boutique investment and advisory firm for the Life Science industry.

Life Science 75

Life Science Drug Development Healthcare Innovation Pharmaceuticals 75

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Healthcare IT Today

JANUARY 8, 2024

Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Discussions will focus on the nuanced packaging and delivery requirements for MABs, emphasizing the commitment to safety standards while ensuring the drugs’ effectiveness.

Health IT 86

Health IT Drug Development Pharmaceuticals BioTech 86

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS –(BUSINESS WIRE)– Medable Inc. , Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

The Digital Health Corner

MARCH 26, 2018

Blockchain technology’s potential impact on the life sciences industry (drug development, distribution and prescribing) is significant. It can impact the opioid crisis and improve tracking drugs in the supply chain.

Digital Health 117

Digital Health Interoperability Life Science Healthcare Data Security 117

Healthcare IT Today

DECEMBER 6, 2024

As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, performance, and scalability of computational pathology analyses for drug development and diagnostics. Aignostics is funded by leading investors and has operations in Berlin and New York.

Life Science 58

Life Science Drug Development Health IT Healthcare IT 58

Healthcare IT Today

MAY 22, 2023

.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.

Life Science 61

Life Science Drug Development Health IT Healthcare IT 61

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” For more information, please visit www.avilar-tx.com and follow us on Twitter @Avilar_Tx and on LinkedIn.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.

Life Science 88

Life Science BioTech Drug Development Health science 88

Lloyd Price

NOVEMBER 16, 2024

The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services.

Drug Development 65

Drug Development healthcare technology Leadership Life Science 65

Digital Health Global

SEPTEMBER 28, 2023

Investments will focus on the next generation of pharma R&D to accelerate drug development, on new technology solutions enabling a more patient-centric approach in clinical trials, and on digital platforms uncovering new insights from clinical data for more personalized care pathways.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Healthcare IT Today

NOVEMBER 14, 2022

Mountain Group Partners is an investor dedicated to investing in and actively guiding transformational businesses in the Technology, Animal Health, and Life Sciences sectors. Technology investments focus on business and healthcare technology, targeting those ideas with quantifiable development risk and a rapid path to market.

Life Science 96

Life Science HIPAA Drug Development healthcare technology 96

Healthcare IT Today

JULY 25, 2022

Cornerstone’s founders incubated the company in partnership with Initiate Studios, a new venture studio that co-creates companies at the intersection of healthcare, life sciences and technology. Poor quality data leads to drug development being delayed, patients being misdiagnosed and inaccurate scientific conclusions.

Life Science 98

Life Science Drug Development Digital Health Health Data 98

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Dr. Bernd Seizinger, M.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

DECEMBER 8, 2018

Life-sciences companies recorded the strongest gains, Fenwick found, with their valuations rising 110% compared with their prior funding rounds. But key facets of its business didn’t develop as planned, say people familiar with the company.

Pharmaceuticals 57

Pharmaceuticals Life Science BioTech Drug Development 57

Lloyd Price

FEBRUARY 18, 2024

Pharmaceutical and Life Sciences Companies: These companies are looking for HealthTech solutions to: Enhance clinical trials and drug development processes. Develop personalized medicine approaches. Examples: CVS Health acquiring telemedicine provider Aetna, Ascension acquiring teleICU company Aidiant.

Pharmaceuticals 65

Pharmaceuticals healthcare technology Digital Health Remote care 65

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 65

Pharmaceuticals Digital Health Drug Development Life Science 65

Digital Health Global

MAY 21, 2024

Food and Drug Administration, biomedical and life science companies, nonprofits, patient-focused groups, and other organizations to transform the current model for developing new diagnostics and treatments. ALS is a progressive and ultimately fatal neurological disease with few treatment options and no cure yet.

Life Science 88

Life Science Drug Development Digital Health Health Technology 88

Henry Kotula

MARCH 10, 2021

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. Patient insight management will be a key strategic pillar: Life science organizations are more confident in the business value of insights management and are increasingly willing to commit the necessary technological resources to support this need.

Health IT 80

Health IT Pharmaceuticals Drug Development Life Science 80

Healthcare IT Today

JANUARY 17, 2024

Precision medicine will continue to evolve in 2024: In disease areas like oncology, we will start to see AI playing a larger role in target discovery and biomarker or patient subpopulation identification, the cornerstones to early precision drug development.

Health IT 99

Health IT Mental health Interoperability Patient Experience 99